Analyst Ratings for aTyr Pharma (LIFE)

LIFE Rating Summary

LIFE Price Target Summary

* Over Last 12-Mos
  |   Expand Research on LIFE
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $25.00 (+602.2%) * Over Last 12-Mos
Rating Score: 2.5 / 10   Percentile Rank: 54%
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
4/12/2016 BMO Capital New Coverage Market Perform
(N/A)
8.00
(N/A)
3.62 3.56 -1.66% Details
3/31/2016 William Blair Downgrade Market Perform
(Outperform)
N/A
(N/A)
4.86 3.56 -26.75% Details
Like LIFE Ratings? Also take a look at MDCO, OPK

LIFE Ratings News